Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3642215 | 0.83 | CYP1A2 (0.35) | EPHX1CYP1A2CA1CA2CA4 | |
| SCHEMBL21441575 | 0.79 | UGT2B7 (0.34) | EPHX1CYP1A2CA1CA2CA4 | |
| SCHEMBL4608224 | 0.79 | UGT2B7 (0.34) | EPHX1CYP1A2CA1CA2CA4 | |
| SCHEMBL4606059 | 0.79 | UGT2B7 (0.34) | EPHX1CYP1A2CA1CA2CA4 | |
| SCHEMBL4605622 | 0.79 | UGT2B7 (0.34) | EPHX1CYP1A2CA1CA2CA4 | |
| SCHEMBL4605915 | 0.79 | UGT2B7 (0.34) | EPHX1CYP1A2CA1CA2CA4 | |
| SCHEMBL814238 | 0.79 | UGT2B7 (0.34) | EPHX1CYP1A2CA1CA2CA4 | |
| SCHEMBL3744024 | 0.79 | ALDH1A1 (0.33) | EPHX1CYP1A2 | |
| SCHEMBL3639450 | 0.79 | ALDH1A1 (0.33) | EPHX1CYP1A2 | |
| SCHEMBL3751050 | 0.79 | ALDH1A1 (0.33) | EPHX1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167621-B1 | ORGANIC COMPOUNDS AS ODORANTS | GIVAUDAN SA (CH) | 2017-10-11 | — | — | EP | disclosed |
| US-9012391-B2 | Organic compounds | GIVAUDAN SA (CH) | 2015-04-21 | — | — | US | disclosed |
| US-20100292128-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292128-A1 | Organic Compounds | TRPA1, FASN, OR10J3 | EPHX1 1763/4885CYP1A2 425/4885CA1 4266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.